These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8582890)

  • 1. Radiological case of the month. Ductal carcinoma in situ.
    DeLoach J; Hayes J; Stair M; Ludwig F; Bevans D; Fielder C; Harshfield D
    J Ark Med Soc; 1996 Jan; 92(8):415-8. PubMed ID: 8582890
    [No Abstract]   [Full Text] [Related]  

  • 2. When is core breast biopsy or fine-needle aspiration not enough?
    Berg WA
    Radiology; 1996 Feb; 198(2):313-5. PubMed ID: 8596822
    [No Abstract]   [Full Text] [Related]  

  • 3. Ductal carcinoma in situ of the breast: mammographic-pathologic correlation.
    Poplack SP; Wells WA
    AJR Am J Roentgenol; 1998 Jun; 170(6):1543-9. PubMed ID: 9609171
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous removal of malignant mammographic lesions at stereotactic vacuum-assisted biopsy.
    Liberman L; Dershaw DD; Rosen PP; Morris EA; Abramson AF; Borgen PI
    Radiology; 1998 Mar; 206(3):711-5. PubMed ID: 9494489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound of malignant breast microcalcifications: role in evaluation and guided procedures.
    Rickard MT
    Australas Radiol; 1996 Feb; 40(1):26-31. PubMed ID: 8838884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical case. Radiologic-pathologic correlations in breast diseases].
    Tardivon A
    J Radiol; 2002 Apr; 83(4 Pt 2):565-6. PubMed ID: 12075163
    [No Abstract]   [Full Text] [Related]  

  • 7. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.
    Evans A; Pinder S; Wilson R; Sibbering M; Poller D; Elston C; Ellis I
    AJR Am J Roentgenol; 1994 Jun; 162(6):1307-11. PubMed ID: 8191988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy.
    Dershaw DD; Morris EA; Liberman L; Abramson AF
    Radiology; 1996 Feb; 198(2):323-5. PubMed ID: 8596825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer?
    Weaver DL; Vacek PM; Skelly JM; Geller BM
    Ann Surg Oncol; 2005 Aug; 12(8):660-73. PubMed ID: 15968496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive breast cancer: mammographic measurement.
    Flanagan FL; McDermott MB; Barton PT; Pilgram TK; Dehdashti F; Wick MR; Monsees BS
    Radiology; 1996 Jun; 199(3):819-23. PubMed ID: 8638011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of nonpalpable mammographic abnormalities using guidewire localization].
    Ben Aharon U; Lifscitz O; Strano SD; Mavor E; Barzilai N
    Harefuah; 1995 Feb; 128(4):205-7, 264. PubMed ID: 7744325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between mammographic manifestations and averaged histopathologic nuclear grade using prognosis-predict scoring system for the prognosis of ductal carcinoma in situ.
    Lee KS; Han BH; Chun YK; Kim HS; Kim EE
    Clin Imaging; 1999; 23(6):339-46. PubMed ID: 10899414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesions entirely removed during stereotactic biopsy: preoperative localization on the basis of mammographic landmarks and feasibility of freehand technique--initial experience.
    Brenner RJ
    Radiology; 2000 Feb; 214(2):585-90. PubMed ID: 10671616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy.
    Meyer JE; Smith DN; Lester SC; DiPiro PJ; Denison CM; Harvey SC; Christian RL; Richardson A; Ko WD
    Radiology; 1998 Mar; 206(3):717-20. PubMed ID: 9494490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographically detected ductal carcinoma in situ: are we overdiagnosing breast cancer?
    Jatoi I; Baum M
    Surgery; 1995 Jul; 118(1):118-20. PubMed ID: 7604373
    [No Abstract]   [Full Text] [Related]  

  • 16. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations.
    Barreau B; de Mascarel I; Feuga C; MacGrogan G; Dilhuydy MH; Picot V; Dilhuydy JM; de Lara CT; Bussières E; Schreer I
    Eur J Radiol; 2005 Apr; 54(1):55-61. PubMed ID: 15797293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective.
    Georgian-Smith D; Lawton TJ
    Radiol Clin North Am; 2010 Sep; 48(5):999-1012. PubMed ID: 20868897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of malignant breast microcalcifications.
    Lev-Toaff AS; Feig SA; Saitas VL; Finkel GC; Schwartz GF
    Radiology; 1994 Jul; 192(1):153-6. PubMed ID: 8208928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ: the mammographer's perspective.
    Stomper PC; Margolin FR
    AJR Am J Roentgenol; 1994 Mar; 162(3):585-91. PubMed ID: 8109501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.
    Evans AJ; Pinder S; Ellis IO; Sibbering M; Elston CW; Poller DN; Wilson R
    Radiology; 1994 Apr; 191(1):237-40. PubMed ID: 8134579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.